Marijuana
How to Trade Cronos, the Cannabis Firm With Ties to Big Tobacco
What matters here is the ability to innovate, market, and sell.
Who Hasn't Crashed the Cannabis Party Yet?
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
Chart of the Day, Part 2: Tilray's Deal is Tiny Compared to Canopy's
Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.
Chart of the Day, Part 1: Tilray, AB Deal Pales in Comparison to Cronos
The buy-in from other companies into the space has been far larger.
Canopy Growth Could Go Higher as Cannabis Bubble Talk Seems Overblown
Commentators who dismiss cannabis stocks as a fad should take a closer look at the charts of Canopy Growth.
Cannabis Shorts: Is There Enough Liquidity?
Before you short cannabis names, read this.
California's Exploding Cannabis Industry Has a Surprising Problem With Cash
The cannabis industry in California continues to flourish. But, those doing business in the industry they may be having an interesting cash problem.
Podcast: What Does the Cannabis Industry Have in Common with the Dot-Com?
Does the smoking cannabis industry share more than a few things in common with the Dot-com in the 1990s. Check out this podcast from the Real Money team.
Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players
Tilray is full steam ahead in taking on some established players in the food and drug industry. CEO Brendan Kennedy discusses the company's efforts to grow.
How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray
Cannabis company Tilray is fresh off a smoking hot IPO this week. TheStreet talks with Tilray's CEO Brendan Kennedy about how he came to the cannabis industry.